IP Library Granted Patent US 10,620,214
Granted Patent B2
US 10,620,214 · App. 15/818,282 · Granted Apr 14, 2020

Chloroalkane penetration method for quantifying access of a molecule into a cell

Inventors: Joshua Kritzer (Medford, MA); Leila Peraro (Medford, MA)
Assignee: TRUSTEES OF TUFTS COLLEGE
G01N33/582C12N9/0006C12Q1/32C07K2319/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,620,214
App. No.
15/818,282
Granted
Apr 14, 2020
Kind
B2
Abstract

As described below, the invention provides methods for localizing and quantifying the extent to which a molecule penetrates a cell.

Claims (12)

1. A method for quantifying cell penetration of an agent, the method comprising:

(a) contacting a cell expressing a chloroalkane dehalogenase haloenzyme comprising SEQ ID NO: 1 with an agent conjugated to chloroalkane in a first step;

(b) contacting the cell with chloroalkane conjugated to a fluorescent detectable moiety in a second step following step (a); and

(c) measuring the relative amount of cellular fluorescence following steps (a) and (b) by detecting a fluorescent signal from the detectable moiety, wherein the fluorescent signal indicates the amount of free haloenzyme, which is inversely proportional to the signal associated with binding of the haloenzyme to the agent conjugated to chloroalkane in the cell, and wherein the signal quantifies the cell penetration of the agent conjugated to chloroalkane.

2. The method of claim 1 , wherein the agent is selected from the group consisting of a bacterium, nucleic acid molecule, polypeptide, peptide, small molecule, viral particle, nanoparticle, and macromolecule.

3. The method of claim 1 , wherein the detectable moiety is a cell permeable fluorescent tag.

4. The method of claim 1 , wherein the cell expresses a fusion protein comprising chloroalkane dehalogenase haloenzyme fused to a detectable reporter that localizes the fusion protein to one or more of the nucleus, mitochondria, or cytoplasm.

5. The method of claim 4 , wherein the signal from the detectable moiety co-localizes with the signal from the detectable reporter.

6. The method of claim 4 , wherein the cell is a eukaryotic or prokaryotic cell.

7. The method of claim 1 , wherein the agent comprises a free amine group and is conjugated with chloroalkane by covalently linking the free amine group and a chloroalkane ligand.

8. The method of claim 7 , wherein the free amine group is conjugated to the chloroalkane ligand in the presence of a coupling agent.

9. The method of claim 8 , wherein the coupling agent is benzotriazol-1-yl-oxytripyrrolidino-phosphonium hexafluorophosphate (PyBOP).

Assignments (3)
CONFIRMATORY LICENSE Recorded Dec 10, 2019
From: TUFTS UNIVERSITY BOSTON
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 051245/0853 →
CORRECTIVE ASSIGNMENT TO CORRECT THE SPELLING OF THE SECOND ASSIGNORS NAME PREVIOUSLY RECORDED ON REEL 044700 FRAME 0482. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jan 25, 2018
From: KRITZER, JOSHUA; PERARO, LEILA
To: TRUSTEES OF TUFTS COLLEGE
Reel/Frame 045154/0665 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 23, 2018
From: KRITZER, JOSHUA; PERARO, LELIA
To: TRUSTEES OF TUFTS COLLEGE
Reel/Frame 044700/0482 →
Continuity (2)
Provisional Application 62424955 · Nov 21, 2016
Related Publication 20180188260A1 · Jul 5, 2018